Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Axogen Inc (AXGN)  
$6.63 0.11 (1.69%) as of 4:30 Fri 4/26


Download
   
Exchange: OTC Bulletin Board
Security Type: Common
Shares Out: 41,560,000
Market Cap: 275.54(M)
Last Volume: 5,200 Avg Vol: 5,185
52 Week Range: $3.61 - $10.69
Level I Sector: Health Care
Level II Sector: Health Services
Level III Sector: Medical Appliances & Equipment

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Axogen is focused on the science, development and commercialization of technologies for peripheral nerve regeneration and repair. Co.'s platform for peripheral nerve repair features a portfolio of products, including Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; and Axoguard Nerve Connector, a porcine submucosa extracellular matrix coaptation aid for tensionless repair of severed peripheral nerves. Co. also provides Axotouch Two-Point Discriminator, which is used to measure the innervation density of any surface area of the skin.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 30,000 30,000
Total Buy Value $0 $0 $188,940 $188,940
Total People Bought 0 0 3 3
Total Buy Transactions 0 0 3 3
Total Shares Sold 118,082 130,582 180,030 368,410
Total Sell Value $980,899 $1,074,708 $1,509,387 $3,484,755
Total People Sold 5 6 6 6
Total Sell Transactions 6 7 9 21
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 470
  Page 1 of 19  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Zaderej Karen L. CEO   •       •      –    2024-03-21 4 S $7.68 $301,670 D/D (39,280) 1,143,788 15%     
   Scopelianos Angelo Chief R&D Officer   •       –      –    2024-03-21 4 S $7.68 $52,846 D/D (6,881) 57,994 15%     
   Scopelianos Angelo Chief R&D Officer   •       –      –    2024-03-21 4 OE $0.00 $0 D/D 2,500 58,604     -
   Devinney Erick Wayne Chief Innovation Officer   •       –      –    2024-03-21 4 S $7.68 $35,159 D/D (4,578) 177,474 15%     
   Donovan Michael Patrick VP Operations   •       –      –    2024-03-21 4 S $7.68 $46,333 D/D (6,033) 54,250 15%     
   Zaderej Karen L. CEO   •       •      –    2024-03-16 4 OE $0.00 $0 D/D 110,322 1,146,954     -
   Scopelianos Angelo Chief R&D Officer   •       –      –    2024-03-16 4 OE $0.00 $0 D/D 25,406 57,124     -
   Devinney Erick Wayne Chief Innovation Officer   •       –      –    2024-03-16 4 OE $0.00 $0 D/D 18,675 180,615     -
   Donovan Michael Patrick VP Operations   •       –      –    2024-03-16 4 OE $0.00 $0 D/D 24,575 58,846     -
   Freitag Gregory Gene Director   –       •      –    2024-03-07 4 S $9.00 $225,000 D/D (25,000) 271,594 28%     
   Donovan Michael Patrick VP Operations   •       –      –    2024-03-07 4 S $8.81 $319,891 D/D (36,310) 35,708 28%     
   Devinney Erick Wayne Chief Innovation Officer   •       –      –    2024-03-01 4 A $0.00 $0 D/D 50,000 163,377     -
   Kemp Jens Chief Marketing OfficerOfficer   •       –      –    2024-01-01 3 IO $0.00 $0 D/D 0 30,000 -6%     
   Naor Nir CFO   •       –      –    2024-01-01 4 A $0.00 $0 D/D 300,000 300,000     -
   Mariani Peter J EVP & Chief Financial Officer   •       –      –    2023-12-11 4 S $7.50 $93,809 D/D (12,500) 63,603 8%     
   Mariani Peter J EVP & Chief Financial Officer   •       –      –    2023-10-13 4 D $4.04 $13,183 D/D (3,263) 76,103     -
   Devinney Erick Wayne VP Peripheral Nerve Science   •       –      –    2023-10-13 4 D $4.04 $3,491 D/D (864) 113,377     -
   Martinez Maria D. Chief Human Resources Officer   •       –      –    2023-10-13 4 D $4.04 $5,668 D/D (1,403) 30,476     -
   Scopelianos Angelo Chief R&D Officer   •       –      –    2023-10-13 4 D $4.04 $5,668 D/D (1,403) 36,969     -
   Donovan Michael Patrick VP Operations   •       –      –    2023-10-13 4 D $4.04 $5,668 D/D (1,403) 72,018     -
   Wendell Amy Mcbride Director   –       •      –    2023-09-06 4 B $6.22 $62,240 D/D 10,000 80,342 2.39 29%     
   Burke Willaim P Director   –       •      –    2023-08-24 4 A $6.31 $37,860 D/D 6,000 6,000     -
   Burke Willaim P Director   –       •      –    2023-08-23 4 B $6.56 $65,600 I/I 10,000 10,000 2.1 6%     
   Neels Guido J Director   –       •      –    2023-08-16 4 B $6.11 $61,100 D/D 10,000 68,259 2.39 24%     
   Mariani Peter J EVP & Chief Financial Officer   •       –      –    2023-07-18 4 A $0.00 $0 D/D 3,709 79,366     -
  470 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 19
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us